Structural and metabolic effects of obesity on the myocardium and the aorta

Obesity Facts

Volumn 7, Issue 5, 2014, Pages 329-338

  Rider, Oliver J ^a   Lewis, Andrew J M ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac imaging techniques; Cardiovascular diseases; Obesity

Indexed keywords

ADENOSINE TRIPHOSPHATE; LEPTIN; LEPTIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

AORTA; BARIATRIC SURGERY; BLOOD VOLUME; BODY MASS; CARDIAC IMAGING; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; DIASTOLIC DYSFUNCTION; ENERGY METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART DILATATION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART OUTPUT; HUMAN; INSULIN RESISTANCE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LIPID STORAGE; LIPOTOXICITY; MITOCHONDRIAL RESPIRATION; OBESITY; REVIEW; SYSTOLIC HEART FAILURE; WALL STRESS; WEIGHT REDUCTION;

EID: 84908192220     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000368429     Document Type: Review

References (106)

1. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
2. Alpert MA: Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321: 225-236.
3. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P: Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001; 38: 429-433.
4. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP: Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108:7-13.
5. Vakili BA, Okin PM, Devereux RB: Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141:334-341.
6. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
7. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
8. Alexander JK: Obesity and the heart. Heart Dis Stroke 1993; 2: 317-321.
9. Lauer MS, Anderson KM, Levy D: Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1992; 19: 130-134.
10. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
11. Ku CS, Lin SL, Wang DJ, Chang SK, Lee WJ: Left ventricular filling in young normotensive obese adults. Am J Cardiol 1994; 73: 613-615.
12. Messerli FH: Cardiopathy of obesity - a not-so-Victorian disease. N Engl J Med 1986; 314: 378-380.
13. Lavie CJ, Milani RV, Patel D, Artham SM, Ventura HO: Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 2009; 121: 119-125.
14. Kuch B, Muscholl M, Luchner A, Doring A, Riegger GA, Schunkert H, Hense HW: Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens 1998; 12: 685-691.
15. Turkbey EB, McClelland RL, Kronmal RA, Burke GL, Bild DE, Tracy RP, Arai AE, Lima JA, Bluemke DA: The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (mesa). JACC Cardiovasc Imaging 2010; 3: 266-274.
16. Rider OJ, Francis JM, Ali MK, Byrne J, Clarke K, Neubauer S, Petersen SE: Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2009; 11: 9.
17. Rider OJ, Petersen SE, Francis JM, Ali MK, Hudsmith LE, Robinson MR, Clarke K, Neubauer S: Ventricular hypertrophy and cavity dilatation in relation to body mass index in females with uncomplicated obesity. Heart 2011; 97: 203-208.
18. Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M: Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 2004; 287:H2877-2884.
19. Madani S, De Girolamo S, Munoz DM, Li RK, Sweeney G: Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 2006; 69: 716-725.
20. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M: The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93: 277-279.
21. Tajmir P, Ceddia RB, Li RK, Coe IR, Sweeney G: Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 2004; 145: 1550-1555.
22. Abe Y, Ono K, Kawamura T, Wada H, Kita T, Shimatsu A, Hasegawa K: Leptin induces elongation of cardiac myocyte and causes eccentric left ventricular dilatation with compensation. Am J Physiol Heart Circ Physiol 2007
23. Zeidan A, Javadov S, Karmazyn M: Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res 2006; 72: 101-111.
24. Banks AS, Davis SM, Bates SH, Myers MG, Jr.: Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275: 14563-14572.
25. Ghilardi N, Skoda RC: The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997; 11: 393-399.
26. Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, Barbieri M, Morabito A, Paolisso G, Folli F, Pontiroli AE: Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab 2005; 90: 4087-4093.
27. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS: Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 1996; 93: 800-809.
28. Thomas F, Bean K, Pannier B, Oppert JM, Guize L, Benetos A: Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 2005; 46: 654-659.
29. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ: Body-mass index and mortality among 1.46 million white adults. N Engl J Med;363: 2211-2219.
30. Pasco JA, Nicholson GC, Brennan SL, Kotowicz MA: Prevalence of obesity and the relationship between the body mass index and body fat: cross-sectional, population-based data. PLoS One 2012; 7:e29580.
31. Rider OJ, Lewandowski A, Nethononda R, Petersen SE, Francis JM, Pitcher A, Holloway CJ, Dass S, Banerjee R, Byrne JP, Leeson P, Neubauer S: Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur Heart J 2013; 34: 292-299.
32. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlof B, Devereux RB: Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the Life Study). Eur J Echocardiogr 2008; 9: 809-815.
33. Krumholz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-884.
34. Liao Y, Cooper RS, Mensah GA, McGee DL: Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995; 92: 805-810.
35. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS: Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol 2006; 98: 116-120.
36. Ito K, Date T, Kawai M, Nojiri A, Narui R, Hioki M, Tanigawa S, Yamashita S, Tokuda M, Inada K, Matsuo S, Yamane T, Yoshimura M: Morphological change of left atrium in obese individuals. Int J Cardiol 2011; 152: 117-119.
37. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH: Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081-3087.
38. Scaglione R, Dichiara MA, Indovina A, Lipari R, Ganguzza A, Parrinello G, Capuana G, Merlino G, Licata G: Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 1992; 13: 738-742.
39. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165: 55-61.
40. Kydd A, Pugh PJ: Perils of weight loss: the advantage of being obese in patients with heart failure. Expert Rev Cardiovasc Ther 2009; 7: 263-267.
41. Fluchter S, Haghi D, Dinter D, Heberlein W, Kuhl HP, Neff W, Sueselbeck T, Borggrefe M, Papavassiliu T: Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring) 2007; 15: 870-878.
42. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB: Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002; 105: 1928-1933.
43. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, Porcellati C, de Simone G, Mannarino E: Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39: 2005-2011.
44. Otto ME, Belohlavek M, Khandheria B, Gilman G, Svatikova A, Somers V: Comparison of right and left ventricular function in obese and nonobese men. Am J Cardiol 2004; 93: 1569-1572.
45. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, Davila-Roman VG: Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue doppler imaging. J Am Coll Cardiol 2004; 43: 1399-1404.
46. Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD, Byrne JP, Clarke K, Neubauer S: Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009; 54: 718-726.
47. Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, Di Tullio MR: Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 2011; 57: 1368-1374.
48. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A: Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 1999; 99: 2261-2267.
49. Leite-Moreira AF: Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 2006; 92: 712-718.
50. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED: Mito-chondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007; 56: 2457-2466.
51. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED: Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005; 112: 2686-2695.
52. Perseghin G, Ntali G, De Cobelli F, Lattuada G, Esposito A, Belloni E, Canu T, Costantino F, Ragogna F, Scifo P, Del Maschio A, Luzi L: Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 2007; 30: 1520-1526.
53. Rider OJ, Francis JM, Ali MK, Holloway C, Pegg T, Robson MD, Tyler D, Byrne J, Clarke K, Neubauer S: Effects of cate-cholamine stress on diastolic function and myocardial energetics in obesity. Circulation 2012; 125: 1511-1519.
54. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK: Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328-335.
55. Norris SM, Bombardier E, Smith IC, Vigna C, Tupling AR: ATP consumption by sarcoplasmic reticulum Ca2+ pumps accounts for 50% of resting metabolic rate in mouse fast and slow twitch skeletal muscle. Am J Physiol Cell Physiol 2010; 298:C521-529.
56. Neubauer S: The failing heart - an engine out of fuel. N Engl J Med 2007; 356: 1140-1151.
57. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K: Uncoupling proteins in human heart. Lancet 2004; 364: 1786-1788.
58. Ashrafian H, Frenneaux MP, Opie LH: Metabolic mechanisms in heart failure. Circulation 2007; 116: 434-448.
59. Opie LH: Substrate utilization and glycolysis in the heart. Cardiology 1971; 56: 2-21.
60. Varma N, Eberli FR, Apstein CS: Increased diastolic chamber stiffness during demand ischemia: response to quick length change differentiates rigor-activated from calcium-activated tension. Circulation 2000; 101: 2185-2192.
61. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-257.
62. Stanley WC, Recchia FA, Lopaschuk GD: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093-1129.
63. Wisneski JA, Stanley WC, Neese RA, Gertz EW: Effects of acute hyperglycemia on myocardial glycolytic activity in humans. J Clin Invest 1990; 85: 1648-1656.
64. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M: Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci 2004; 1015: 202-213.
65. Wall SR, Lopaschuk GD: Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1989; 1006: 97-103.
66. Vyska K, Machulla HJ, Stremmel W, Fassbender D, Knapp WH, Notohamiprodjo G, Gleichmann U, Meyer H, Knust EJ, Korfer R: Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation 1988; 78: 1218-1233.
67. Bing RJ, Siegel A, Ungar I, Gilbert M: Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am J Med 1954; 16: 504-515.
68. Koutsari C, Jensen MD: Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 47: 1643-1650.
69. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004; 109: 2191-2196.
70. Lopaschuk GD, Russell JC: Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat. J Appl Physiol 1991; 71: 1302-1308.
71. Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostag Leukotr Ess 2004; 70: 309-319.
72. Cole MA, Murray AJ, Cochlin LE, Heather LC, McAleese S, Knight NS, Sutton E, Abd Jamil A, Parassol N, Clarke K: A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res Cardiol 2011; 106: 447-457.
73. Veech RL, Kashiwaya Y, Gates DN, King MT, Clarke K: The energetics of ion distribution: The origin of the resting electric potential of cells. IUBMB Life 2002; 54: 241-252.
74. Korvald C, Elvenes OP, Myrmel T: Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart C 2000; 278:H1345-H1351.
75. Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC: Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010; 90: 207-258.
76. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'Armiento J, Abel ED, Goldberg IJ: Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006; 281: 8716-8723.
77. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737.
78. Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM: Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir Ther 2007; 12: 205-216.
79. Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-435.
80. Chandran M, Phillips SA, Ciaraldi T, Henry RR: Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26: 2442-2450.
81. Barger PM, Kelly DP: PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 2000; 10: 238-245.
82. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273: 16710-16714.
83. Van Bilsen M, de Vries JE, Van der Vusse GJ: Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes. Prostaglandins Leukot Essent Fatty Acids 1997; 57: 39-45.
84. van der Lee KA, Vork MM, De Vries JE, Willemsen PH, Glatz JF, Reneman RS, Van der Vusse GJ, Van Bilsen M: Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 2000; 41: 41-47.
85. Djouadi F, Brandt JM, Weinheimer CJ, Leone TC, Gonzalez FJ, Kelly DP: The role of the peroxisome proliferator-activated receptor alpha (PPAR alpha) in the control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 339-343.
86. Pagano C, Calcagno A, Granzotto M, Calabrese F, Thiene G, Federspil G, Vettor R: Heart lipid accumulation in obese non-diabetic rats: effect of weight loss. Nutr Metab Cardiovasc Dis 2008; 18: 189-197.
87. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE: A novel mouse model of lipo-toxic cardiomyopathy. J Clin Invest 2001; 107: 813-822.
88. Young ME, McNulty P, Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 2002; 105: 1861-1870.
89. Taegtmeyer H, McNulty P, Young ME: Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 2002; 105: 1727-1733.
90. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP: A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A 2003; 100: 1226-1231.
91. Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR: Shedding light on the enigma of myocardial lipotox-icity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2010; 298:E897-908.
92. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000; 97: 1784-1789.
93. Rider OJ, Tayal U, Francis JM, Ali MK, Robinson MR, Byrne JP, Clarke K, Neubauer S: The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging. Obesity (Silver Spring) 2010; 18: 2311-2316.
94. Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002; 106: 1919-1924.
95. Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ: Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol 2003; 91: 195-199.
96. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-809.
97. Edirisinghe I, McCormick Hallam K, Kappagoda CT: Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta. Clin Sci (Lond) 2006; 111: 145-151.
98. Rider OJ, Holloway CJ, Emmanuel Y, Bloch E, Clarke K, Neubauer S: Increasing plasma free fatty acids in healthy subjects induces aortic distensibility changes seen in obesity. Circ Cardiovasc Imaging 2012; 5: 367-375.
99. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC: Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761.
100. Sampalis JS, Liberman M, Auger S, Christou NV: The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg 2004;14: 939-947.
101. Leichman JG, Aguilar D, King TM, Mehta S, Majka C, Scarborough T, Wilson EB, Taegtmeyer H: Improvements in systemic metabolism, anthropometrics, and left ventricular geometry 3 months after bariatric surgery. Surg Obes Relat Dis 2006; 2: 592-599.
102. Varli M, Turhan S, Aras S, Atli T, Erdogan G: Effects of weight loss on ventricular systolic and diastolic functions and left ventricular mass assessed by tissue doppler imaging in obese geriatric women: preliminary report. Aging Clin Exp Res 2010; 22: 206-211.
103. de las Fuentes L, Waggoner AD, Mohammed BS, Stein RI, Miller BV 3rd, Foster GD, Wyatt HR, Klein S, Davila-Roman VG: Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol 2009; 54: 2376-2381.
104. Kosmala W, O'Moore-Sullivan T, Plaksej R, Przewlocka-Kosmala M, Marwick TH: Improvement of left ventricular function by lifestyle intervention in obesity: Contributions of weight loss and reduced insulin resistance. Diabetologia 2009; 52: 2306-2316.
105. Hughes TM, Althouse AD, Niemczyk NA, Hawkins MS, Kuipers AL, Sutton-Tyrrell K: Effects of weight loss and insulin reduction on arterial stiffness in the save trial. Cardiovasc Diabetol 2012; 11: 114.
106. Rider OJ, Francis JM, Tyler D, Byrne J, Clarke K, Neubauer S: Effects of weight loss on myocardial energetics and diastolic function in obesity. Int J Cardiovasc Imaging 2013; 29: 1043-1050.